Please login to the form below

Not currently logged in
Email:
Password:

PhRMA names advocacy chief

Pharmaceutical Research and Manufacturers of America has named AZ's Chip Davis to serve as executive vice president of advocacy

Pharmaceutical Research and Manufacturers of America (PhRMA) has named AstraZeneca's (AZ) Chip Davis to serve as executive vice president of advocacy, a newly created position, effective immediately.

Davis has been on a leave of absence from his post as vice president of corporate External Relations at AZ since mid-April, when he joined PhRMA to serve as senior operating officer, providing day-to-day leadership at the trade organisation following the departure of the trade group's CEO, Billy Tauzin. He also played a key role in the search for Tauzin's replacement, a process that was led by AZ CEO David Brennan.

In his permanent position at PhRMA, he will be responsible for leading the organisation's federal, state and international government relations and advocacy efforts.

Before his leave of absence from AZ, Davis was the company's official liaison to PhRMA, a responsibility he took on beginning in 2004.  He was also responsible for overseeing the pharma firm's government relations and reimbursement teams, as well as strategic alliances and community relations.

After Davis took on the role of senior operating officer at PhRMA, there was speculation in the trade press and in Internet communities that he would eventually be named the organisation's CEO. However, that role in the end went to John Castellani, formerly president of the Business Roundtable, and Davis stayed on to help manage the transition. In his new role, Davis reports directly to Castellani.

Davis holds an undergraduate degree in accounting from the University of Delaware and a law degree from the University of Baltimore. He is a member of the bar in the District of Columbia, Maryland and Virginia.

15th November 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles

With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize...

Latest intelligence

Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
...

Infographics